Giant gastrointestinal stromal tumor presenting as a palpable abdominal mass: an unusual presentation.

ISRN surgery Pub Date : 2011-01-01 Epub Date: 2011-06-16 DOI:10.5402/2011/894829
Sachin Patil, Sudhir Jain, R C M Kaza, Ronald S Chamberlain
{"title":"Giant gastrointestinal stromal tumor presenting as a palpable abdominal mass: an unusual presentation.","authors":"Sachin Patil,&nbsp;Sudhir Jain,&nbsp;R C M Kaza,&nbsp;Ronald S Chamberlain","doi":"10.5402/2011/894829","DOIUrl":null,"url":null,"abstract":"<p><p>Gastrointestinal stromal tumors (GIST-) account for the majority of mesenchymal tumors arising within the gastrointestinal tract. GIST presenting as a palpable abdominal mass is extremely rare. We report four additional cases of a GIST presenting as an abdominal mass along with a pertinent review of the literature. Twenty five cases of GISTs presenting with an abdominal mass, including 4 cases discussed here, have been reported in the world literature since 2001. The mean duration of symptoms was 152.7 days. Twenty one of 25 (84%) patients received surgical resection. The mean tumor size was 17.2 cm, with an average mitotic index of 7.6 per 50 high power fields. Thirteen of 14 (92.9%) patients had a high-risk tumor. Five patients were disease-free at a mean followup of 11 months, 2 patients had stable disease and 2 patients had progressive disease, and one patient had a partial response. In conclusion, symptomatic patents have an increased incidence of high-risk tumors and metastases at presentation. Adjuvant therapy with imatinib improves disease-free survival in patients with large abdominal GIST tumors, but no change in overall survival was noted. Finally, GISTs should be considered in the differential diagnosis of an abdominal mass in an elderly patient.</p>","PeriodicalId":89400,"journal":{"name":"ISRN surgery","volume":"2011 ","pages":"894829"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/894829","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2011/894829","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2011/6/16 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

Gastrointestinal stromal tumors (GIST-) account for the majority of mesenchymal tumors arising within the gastrointestinal tract. GIST presenting as a palpable abdominal mass is extremely rare. We report four additional cases of a GIST presenting as an abdominal mass along with a pertinent review of the literature. Twenty five cases of GISTs presenting with an abdominal mass, including 4 cases discussed here, have been reported in the world literature since 2001. The mean duration of symptoms was 152.7 days. Twenty one of 25 (84%) patients received surgical resection. The mean tumor size was 17.2 cm, with an average mitotic index of 7.6 per 50 high power fields. Thirteen of 14 (92.9%) patients had a high-risk tumor. Five patients were disease-free at a mean followup of 11 months, 2 patients had stable disease and 2 patients had progressive disease, and one patient had a partial response. In conclusion, symptomatic patents have an increased incidence of high-risk tumors and metastases at presentation. Adjuvant therapy with imatinib improves disease-free survival in patients with large abdominal GIST tumors, but no change in overall survival was noted. Finally, GISTs should be considered in the differential diagnosis of an abdominal mass in an elderly patient.

巨大的胃肠道间质瘤表现为可触及的腹部肿块:一种不寻常的表现。
胃肠道间质瘤(GIST-)在胃肠道间质肿瘤中占多数。GIST表现为可触及的腹部肿块是极为罕见的。我们报告另外四例胃肠道间质瘤表现为腹部肿块,并对相关文献进行回顾。自2001年以来,世界文献报道了25例以腹部肿块为表现的胃肠道间质瘤,其中包括本文讨论的4例。平均症状持续时间为152.7天。25例患者中有21例(84%)接受手术切除。平均肿瘤大小为17.2 cm,平均有丝分裂指数为7.6 / 50倍视场。14例患者中有13例(92.9%)存在高危肿瘤。5例患者平均随访11个月无病,2例病情稳定,2例病情进展,1例部分缓解。总之,症状性专利在出现时增加了高风险肿瘤和转移的发生率。伊马替尼辅助治疗提高了腹部大GIST肿瘤患者的无病生存率,但总体生存率没有变化。最后,在老年患者腹部肿块的鉴别诊断中应考虑gist。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信